Medeze Group (SET:MEDEZE-R) - Stock Price, News & Analysis

MEDEZE-R Stock Overview

Offers stem cell, NK cell, and follicle hair banking services in Thailand.

MEDEZE-R fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	4/6
Past Performance	6/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 25.03% per year

Earnings grew by 38.8% over the past year

Risk Analysis

Shares are highly illiquid

Medeze Group Public Company Limited Competitors

Klinique Medical Clinic

SET:KLINIQ

฿7.0b

Safe Fertility Group

SET:SAFE

฿4.3b

Genesis Fertility Center

SET:GFC

฿1.7b

Bangkok Genomics Innovation

SET:BKGI

฿1.6b

Price History & Performance

Summary of all time highs, changes and price drops for Medeze Group
Historical stock prices
Current Share Price	฿10.00
52 Week High	฿12.00
52 Week Low	฿9.80
Beta	0
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-9.91%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	MEDEZE-R	TH Healthcare	TH Market
7D	-7.4%	-2.6%	-1.5%
1Y	n/a	-4.6%	4.6%

Return vs Industry: Insufficient data to determine how MEDEZE-R performed against the TH Healthcare industry.

Return vs Market: Insufficient data to determine how MEDEZE-R performed against the TH Market.

Price Volatility

Is MEDEZE-R's price volatile compared to industry and market?
MEDEZE-R volatility
MEDEZE-R Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.3%
Market Average Movement	5.0%
10% most volatile stocks in TH Market	11.1%
10% least volatile stocks in TH Market	2.6%

Stable Share Price: MEDEZE-R's share price has been volatile over the past 3 months compared to the TH market.

Volatility Over Time: Insufficient data to determine MEDEZE-R's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2010	n/a	Veerapol Khemarangsan	www.medezegroup.com

Medeze Group Public Company Limited offers stem cell, NK cell, and follicle hair banking services in Thailand. It also provides NK cell activity test and cosmeceutical skin care services, as well as biotech research and development services. The company was founded in 2010 and is based in headquartered in Sam Phran, Thailand.

Medeze Group Public Company Limited Fundamentals Summary

How do Medeze Group's earnings and revenue compare to its market cap?
MEDEZE-R fundamental statistics
Market cap	฿10.68b
Earnings (TTM)	฿270.40m
Revenue (TTM)	฿780.07m

39.5x

P/E Ratio

13.7x

P/S Ratio

Is MEDEZE-R overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MEDEZE-R income statement (TTM)
Revenue	฿780.07m
Cost of Revenue	฿167.21m
Gross Profit	฿612.85m
Other Expenses	฿342.46m
Earnings	฿270.40m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.25
Gross Margin	78.56%
Net Profit Margin	34.66%
Debt/Equity Ratio	0%

How did MEDEZE-R perform over the long term?

See historical performance and comparison